Importantly, the MDS-like anemia could be rescued by enhanced PPAR-signaling, either through PGC1β over-expression or Bezafibrate treatment21, indicating that PGC1β plays a functional role in the anemic phenotype. Here, PPARA is linked to myelodysplastic syndrome.